OVID THERAPEUTICS INC. - COMMON STOCK

Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum

09 3 2023 07:00:01 提供 Nasdaq GlobeNewswire

Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures

08 3 2023 07:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference

28 2 2023 07:00:02 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments

08 2 2023 07:00:01 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial

05 1 2023 07:00:45 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)

02 12 2022 09:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights

08 11 2022 07:00:02 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference

27 9 2022 07:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

07 9 2022 07:00:02 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

09 8 2022 07:00:02 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Presents Preclinical Data on OV329 at the Epilepsy Foundation Pipeline Conference

06 6 2022 07:00:02 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights

10 5 2022 07:00:04 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

08 4 2022 07:00:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results

15 3 2022 07:00:03 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference

04 3 2022 07:00:00 提供 Nasdaq GlobeNewswire

Healx and Ovid Therapeutics to Enter Strategic Partnership

08 2 2022 07:00:03 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators

03 1 2022 05:30:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Reports Third Quarter 2021 Business Update, Corporate Highlights and Financial Results

10 11 2021 07:30:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of Directors

07 10 2021 07:30:00 提供 Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

07 9 2021 07:00:01 提供 Nasdaq GlobeNewswire